Wall Street Zen lowered shares of ANI Pharmaceuticals (NASDAQ:ANIP – Free Report) from a strong-buy rating to a buy rating in a research report released on Saturday. A number of other analysts have also recently commented on ANIP. Zacks Research cut shares of ANI Pharmaceuticals from a “strong-buy” rating to a “hold” rating in a […]

Wall Street Zen downgraded shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) from a hold rating to a sell rating in a research note published on Saturday morning. A number of other research analysts have also weighed in on the company. Citigroup increased their price target on Agios Pharmaceuticals from $38.00 to $46.00 and gave […]

Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Sunday. A number of other research firms have also weighed in on SUPN. Weiss Ratings reaffirmed a “sell (d+)” rating on shares […]